Abstract
Lexchin examines how Pfizer transformed sildenafil from an effective product for erectile dysfunction due to illness or injury into a drug that healthy men can use to enhance their erections.
MeSH terms
-
Adolescent
-
Adult
-
Advertising*
-
Age Factors
-
Drug Costs
-
Drug Industry*
-
Erectile Dysfunction / drug therapy*
-
Erectile Dysfunction / epidemiology
-
Erectile Dysfunction / etiology
-
Erectile Dysfunction / psychology
-
Evidence-Based Medicine
-
Humans
-
Insurance Coverage
-
Life Style*
-
Male
-
Middle Aged
-
Piperazines / economics
-
Piperazines / therapeutic use*
-
Prevalence
-
Purines
-
Resource Allocation
-
Severity of Illness Index
-
Sildenafil Citrate
-
Social Conditions
-
Sulfones
-
Treatment Outcome
-
Vasodilator Agents / economics
-
Vasodilator Agents / therapeutic use*
Substances
-
Piperazines
-
Purines
-
Sulfones
-
Vasodilator Agents
-
Sildenafil Citrate